top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Multiple Sclerosis Research-Series I
Advances in Multiple Sclerosis Research-Series I
Autore Matsoukas John
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (334 p.)
Soggetto topico Medicine
Soggetto non controllato multiple sclerosis
inflammation
oxidative
biomarker
sample size
autoimmune encephalitis
plasma exchange
autoimmunity
immunotherapeutics
clinical outcomes
major depression
bupropion
S-adenosylmethionine
vitamin D3
yoga
craniopharyngioma
fractionated stereotactic radiation treatments
sphenoid sinusitis
cranial nerve-VI palsy
autoimmune diseases
immune thrombocytopenic purpura
alemtuzumab
antibodies against GluR3 peptide
cognitive impairment
diagnosis
neuropsychological assessment
short intracortical inhibition
intracortical facilitation
fampridine
walking disability
TSPAN32
tetraspanins
cellular immunity
memory T cells
tDCS
neuroimaging
positron emission tomography
cerebral blood flow
probiotics
Streptococcus thermophilus
ST285
MBP83–99 peptide
mannan
immune modulation
agonist peptide
gut microbiome
gut–brain axis
metagenomics
disease-modifying treatments
MS
vaccine
immunomodulation
carriers
B cell receptor
delivery methods
immunotherapy
monoclonal antibodies
T cell receptor
tolerance
diagnostic markers
immunoglobulins
kappa
free light chains
antigen-specific immunotherapies
tolerogenic vaccines
tolerance induction
central nervous system
myelin peptides
myelin basic protei
proteolipid protein
myelin oligodendrocyte glycoprotein
nanotechnology
drug delivery nanosystems
lipids
polymers
vaccines
nanoparticles
antigen-specific immunotherapy
experimental autoimmune encephalomyelitis
neurodegeneration
chloroquine
EAE
dendritic cells
microglia
astrocytes
oligodendrocytes
conformational analysis
peptides
altered peptide ligands
NMR spectroscopy
NOE-constraints
molecular dynamic
trimolecular complex
Multiple Sclerosis
early-onset
adult-onset
Human Leucocyte Antigens
immunogenetics
clinical phenotype
clinical outcome
therapeutics
antibody detection
ELISA
multivalency
N-glucosylated peptide epitopes
peptide
conjugation
MOG35-55
Graphite/SiO2 electrode
voltammetry
HPLC
MS drugs
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557385403321
Matsoukas John  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
autophagy
hydroxychloroquine
chloroquine
ROC-325
cysteine cathepsins
cysteine cathepsin inhibitors
lysosome
renal cancer
metastatic renal cell carcinoma
immune-based combination therapies
network meta-analysis
PD-L1
predictive
biomarker
treatment
TKIs
mRCC
biomarkers
soluble factors
immunotherapy
renal cell carcinoma (RCC)
sunitib resistance
artesunate (ART)
Traditional Chinese Medicine (TCM)
growth inhibition
ferroptosis
reactive oxygen species (ROS)
clear cell renal cell carcinoma
ccRCC
RCC
kidney cancer
evolution
evolutionary trajectory
metastatic
second line therapy
renal cell cancer
immune checkpoint inhibitors
tyrosine kinase inhibitors
individualization
genomic signature
transcriptomic analysis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive Phytochemicals in Health and Disease
Bioactive Phytochemicals in Health and Disease
Autore Iriti Marcello
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (264 p.)
Soggetto topico Medicine
Soggetto non controllato quercetin
nervous system
molecular signals
pharmacological potential
cognitive impairment
micronuclei
radioprotectors
radiation effects
melanoma
PNT2
B16F10 cells
Ulmus parvifolia
wound healing
matrix metalloproteinase
transforming growth factor
skin rejuvenation
kaempferol
naringin
orientin
rutin
vitexin
chlorogenic acid
citric acid
malic acid
quinic acid
rosmarinic acid
curcumin
nanocurcumin
neurological disorders
nanocarriers
liposomes
cancer
diet
flavonoids
food supplements
hormesis
phytoestrogens
sulforaphane
resveratrol
cardiovascular disease
nanomedicine
liposome
nanoformulation
RNA-dependent RNA polymerase
remdesivir
chloroquine
SARS-CoV-2
COVID-19
spike glycoproteins
Acorus calamus
ethnomedicinal
phytochemistry
toxicity
pharmacological action
clinical trial
neuroprotective
neurological
metabolic application
kurarinone
coronavirus
HCoV-OC43
autophagy
infection
MRC-5 cell
LC3
p62/SQSTM1 protein
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557389003321
Iriti Marcello  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications
Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications
Autore Luvisetto Siro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (368 p.)
Soggetto topico Medicine
Soggetto non controllato botulinum toxin
limb tremors
muscle selection
biological effect
various cell types
neurotransmitter
dermatology
novel indication
botulinum neurotoxin
masticatory system
maxillofacial bone
dental occlusion
orthognathic surgery
sialorrhoea
drooling
salivary glands
swallowing
eccrine glands
onabotulinumtoxin A
incobotulinumtoxin A
botulinum neurotoxins
botulinum neurotoxin serotype A
heavy chain
botulinum neurotoxin serotype a heavy chain (BoNT/A HC)
spinal cord injury (SCI)
nerve regeneration
growth associated protein 43 (GAP-43)
superior cervical ganglion 10 (SCG10)
neuronal processes
neural regeneration
Schwann cells
glia
spinal cord
immunohistochemistry
allodynia
weight bearing
sciatic static index
walking track analysis
itch
SNARE
VAMP
mast cells
compound 48/80
chloroquine
spasticity
botulinum toxin type A
appropriate treatment
Therapeutic Index
pruritus
antipruritic
clinical
experimental
BoNT/A
astroglia
interleukins
microglia
TLR2
TLR4
Snap-23
pain
cerebral palsy
botulinum toxin A
complex regional pain syndrome
lumbar sympathetic ganglion block
chronic pelvic pain
overactive detrusor
vaginism
temporomandibular joint dislocation
lateral pterygoid muscle
botulinum toxin therapy
synaptic transmission
SNAP-25
epilepsy
Parkinson's disease
neurotransmission blockade
electrical activity
prion disease
new indications
formulation
delivery
refractory chronic migraine
tension headache
medication overuse headache
prophylactic treatment
XEOMIN®
BTX
central neuropathic pain
spinal cord injury
post-stroke shoulder pain
mouse test
Clostridium tetani
botulinum antitoxin
food safety
abobotulinumtoxinA
upper limb spasticity
post-stroke
early use
ONTIME
clinical trial
human
urodynamics
botulinum neurotoxin-A
basal ganglia
interspecies differences in motor behavior
mouse
rat
interneurons
hand tremor
treatment
electromyography
kinematics
essential tremor
dystonic tremor
tremor
movement disorders
Botulinum toxin
upper limb biomechanics
joint biomechanics
diagnostic guidance
clinical decision support
spastic paresis
electrical stimulation
stroke management
rehabilitation
hand
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Botulinum Neurotoxins and Nervous System
Record Nr. UNINA-9910557109003321
Luvisetto Siro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato mucopolysaccharidosis IIIB
quantitative proteomics
NAGLU
lysosomes
Gaucher disease
bone involvement
enzyme replacement therapy
substrate reduction therapy
Osteoimmunology
RANK/RANKL
Osteopontin
MIP-1β
mucolipidosis II
sortilin
TGF-beta
cathepsin D
Fabry disease
alpha-galactosidase A
endocytosis
lysosome
IGF2R/M6P
clathrin
chloroquine
lysosomal diseases
precision medicine
pharmacological chaperones
gene therapy
Pompe disease
lysosomal targeting
autophagy
muscle
satellite cells
rhGAA
glycogen
lysosomal α-glucosidase
GAA biomarker
Gaucher Disease
Wnt/β-catenin
Dkk1
Wnt3a
iPSC
neuronopathy
Krabbe disease
Twitcher mouse
psychosine
visual system
visual cortex
astrogliosis
mucopolysaccharidosis type I
Hurler syndrome
hematopoietic stem cell transplantations
animal models
experimental therapies
axon guidance
lysosomal storage disorders
neuronal circuit
α-galactosidase A
A4GALT
globotriaosylceramide (Gb3)
globotriaosyl-sphingosine (lysoGb3)
pharmacological chaperone therapy
exosomes
endocytic pathways
neurodegenerative disease
Parkinson disease
lysosomal storage disorder
viral vectors
newborn screening
variant interpretation
second tier test
tandem mass spectrometry
lyso-Gb3
dried blood spot
GLA gene
globotriaosylsphingosine
biomarkers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Opioids and Their Receptors : Present and Emerging Concepts in Opioid Drug Discovery II
Opioids and Their Receptors : Present and Emerging Concepts in Opioid Drug Discovery II
Autore Spetea Mariana
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (260 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato thiazole
piperazine
tail-clip
hot-plate
acetic acid-induced writhing test
opioid
prodynorphin
epigenetics
transcription
human brain
morphine dosing
behavior
locomotor activity
tolerance
µ-opioid receptor
DAMGO
SR-17018
buprenorphine
nalbuphine
kappa opioid receptor agonist
pruritis
scratching
mice
TAT-HIV
cholestasis
chloroquine
deoxycholic acid
analgesic
δ opioid receptor
G-protein-biased agonist
opioid peptide
rubiscolins
µ-opioid analgesics
angiotensin receptors
chronic pain
neuropathic pain
delta opioid receptor
inverse agonist
irreversible antagonist
non-competitive antagonist
molecular pharmacology
free fatty acid receptors
lipids
opioid receptor
colitis
chemotype
high-throughput screen
allosteric modulation
beta-arrestin
molecular dynamics
opioid receptors
β-amino acids
peptide synthesis
receptor binding studies
functional assay
nociceptin/orphanin FQ receptor
NOP receptor
ligands
nociceptin
N/OFQ
analgesia
GPCR
HS-731
peripheral opioid agonist
binding
selectivity
molecular docking
molecular dynamics simulations
fluorescence cross-correlation spectroscopy (FCCS)
G protein-coupled receptor (GPCR)
serotonin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Opioids and Their Receptors
Record Nr. UNINA-9910576875203321
Spetea Mariana  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
Autore Drašar Pavel B
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (334 p.)
Soggetto topico Technology: general issues
Chemical engineering
Soggetto non controllato Cannabis sativa (Cannabis)
cannabinoids
tetrahydrocannabinol (THC)
cannabidiol (CBD)
cannabinoid receptors (CB1 and CB2)
Papaver somniferum (opium poppy)
secondary metabolites
ursolic acid
NSCLC
tumorsphere
EGFR
STAT3
MMP2
PD-L1
MAFLD
tanshinone IIA
phytochemical
lipogenesis
lipid accumulation
LXRα
malaria
quinine
chloroquine
artemisinin
onchocerciasis
ivermectin
moxidectin
cancer
vincristine
vinblastine
anabolic
diabetes
Duchenne muscular dystrophy
β-ecdysone
ecdysteroid
ecdysterone
Mas1
osteoporosis
sarcopenia
COVID-19
cardiometabolic diseases
respiratory diseases
natural product
SARS-CoV-2
lung cancer
United States Food and Drug Administration-approved drug
natural remedy
triterpenoid
molecular ribbon
Huisgen 1,3-dipolar cycloaddition
amide bond
multifunctional PEG3 derivative
antimicrobial activity
anti-HIV activity
cytotoxicity
supramolecular self-assembly
phytocannabinoids
cannabichromene
thermos-TRPs
TRPA1
α,α-dimethylheptyl effect
betulinic acid
BODIPY
bevirimat
cell-cycle
fluorescent microscopy
maturation inhibitor
capsaicinoids
endocannabinoidome
microbiota
overweight
obesity
food intake
lipidomics
metabolism
alkaloids
membrane fusion
viral fusion inhibitor
antiviral therapy
curcumin
cancer cells
bioavailability
curcumin derivatives
curcumin analogues
curcumin delivery systems
natural product synthesis
lignans
inflammation
NF-κB inhibition
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580203103321
Drašar Pavel B  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui